---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-120698"
form_type: "8-K"
ticker: "NVAX"
cik: "0001000694"
company_name: "NOVAVAX INC"
filed_at: "2024-11-20T23:59:59+00:00"
generated_at: "2026-05-29T21:31:23.698449+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Novavax to present corporate update at Jefferies London Healthcare Conference

## Summary
- Presentation scheduled for November 20, 2024; no specific numbers or details included in the filing or attached exhibit.
- Form 8-K and Exhibit 99.1 contain only forward-looking cautionary language and generic strategic update references.
- No financial guidance, partnership announcements, or operational metrics provided in the furnished materials.
- Investors directed to company website for full presentation materials.

## SEC filing metadata
- accession: 0001104659-24-120698
- form_type: 8-K
- ticker: NVAX
- cik: 0001000694
- company_name: NOVAVAX INC
- filed_at: 2024-11-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000694/000110465924120698/0001104659-24-120698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000694/000110465924120698/tm2428940d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-120698
- JSON: https://secwatch.observer/filing/0001104659-24-120698.json
- Plain text: https://secwatch.observer/filing/0001104659-24-120698.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.